Clinical Trial Update: Management of Patent Ductus in Premature Infants [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating management of patent ductus arteriosus in premature infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Patent Ductus Arteriosus

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Defect, Congenital Heart | Phase 3 | Status: COMPLETED